Irving, Thomas L.

Tom Irving is Senior Partner at the Marbury Law Group with some 50 years of experience in the field of intellectual property law. My practice emphasizes patent law experting, due diligence investigations, Orange Book listings, and counseling and opinion work, particularly on ODP and MPF. I successfully reissued the patent for the drug Lovenox®, a blockbuster product, and represented targets Agouron, Principia Biopharma, and Endocyte in patent work resulting in deals respectively garnering $2.1, $3.68, and $2.1 billion USD, as publicly reported. I filed an expert report and was cross examined on prosecution laches for CureVac against BioNTech /Pfizer. In settlement, CureVac received $740 million and a running royalty on Covid-19 vaccine sales in the U.S. I have also filed two expert reports dealing with inequitable conduct and one on duty of care in patent filing and prosecution.